COPD

Research aims to develop better tools for dyspnea detection
University of California researcher to launch five-year project to better understand dyspnea in COPD patients.
September 23, 2026
Dyspnea
Novel inhaled treatment for COPD shows promise in clinical trial
Metered spray treatment demonstrated clinically meaningful improvements in quality of life and COPD symptoms.
September 23, 2026
Rejuvenair Device Edit
FDA approves study of inhaled stem cell therapy for COPD
The investigational drug is scheduled for a phase 1b trial in late 2026.
September 17, 2026
Stem Cell Therapy
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Childhood pollution exposure linked to COPD
Children with a higher genetic risk showed reduced lung development but only when exposed to pollution.
September 17, 2026
Childhood Pollution
Getting the last laugh on COPD
Clinical trial suggests laugher therapy may help patients with COPD reduce breathing difficulties.
September 10, 2026
Laughter
Investigational therapy shows promise in treating COPD
Clinical trials show significant reduction in flareups with investigational biologic therapy tozorakimab.
September 10, 2026
Tozarakimab
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Machine learning could help identify lung cancer patients at risk for COPD
A system using a novel systemic coagulation-inflammation index showed promising results.
September 3, 2026
Machine Learning Lungs
Inhaler overuse directly impacts CVD risk, mortality
Research shows overuse is a sign of poor disease control, raising the likelihood of a cardiac event among COPD and asthma patients.
September 3, 2026
Inhaler Overuse
Insurance barriers limit access to care for COPD patients
Researchers find that lack of insurance coverage may prevent COPD patients from receiving virtual pulmonary rehab.
August 26, 2026
Insurance
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
How pollen exposure exacerbates COPD
Pollen season poses surprising danger to COPD patients — here’s why and what helps.
August 26, 2026
Pollen
Improving inhalers for COPD patients
Researchers are using computer modeling combined with particle and pharmaceutical sciences to create a better inhaler.
August 19, 2026
This bisected model of a child’s airway allows researchers to test new inhaler designs to reduce drug deposition in the mouth and throat, increase penetration of particles into the lungs and allow weak inhalation from a young child or very sick person to pull enough medicine into the lungs.
Link found between mental health, COPD
Scientists determine breathlessness caused by COPD breeds vulnerable mental health state.
August 19, 2026
Anxiety2
Page 1 of 26
Next Page
Most Popular
FDA approves study of inhaled stem cell therapy for COPD
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
Novel inhaled treatment for COPD shows promise in clinical trial
Silicosis breakthrough: Epithelial cells are key activators
Common cold: There may be a vaccine for that
MRI reduces cognitive failure, adverse events in SCLC